These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3226000)

  • 21. The challenges of managing urological malignancy in the elderly.
    Abu-Ghanem Y; Dhesi JK; Challacombe BJ
    BJU Int; 2014 Jul; 114(1):12-5. PubMed ID: 24417883
    [No Abstract]   [Full Text] [Related]  

  • 22. New Insights into Diagnosis and Treatment of Renal Cell Carcinoma, Bladder Cancer, and Prostate Cancer.
    Chlosta PL; Golabek T; Nyirády P
    Biomed Res Int; 2017; 2017():6467072. PubMed ID: 28386561
    [No Abstract]   [Full Text] [Related]  

  • 23. [Update on the medical treatment of urologic tumors].
    Culine S
    Bull Cancer; 2000 Jan; 87(1):71-5. PubMed ID: 10673634
    [No Abstract]   [Full Text] [Related]  

  • 24. Adoptive immunotherapy using lymphokine-activated killer cells.
    Fowler JE
    J Urol; 1988 Jan; 139(1):148-9. PubMed ID: 3257273
    [No Abstract]   [Full Text] [Related]  

  • 25. Genitourinary cancer.
    Hudes GR; Grana G; Deshields MS; Ozols RF
    Cancer Chemother Biol Response Modif; 1992; 13():508-40. PubMed ID: 1389919
    [No Abstract]   [Full Text] [Related]  

  • 26. Autologous neoplastic isto-cryoprecipitates as immuno-stimulating treatment in 100 urological cancer patients.
    Marten-Perolino R; Cocimano V; Botto A; Buffa G; Riggi E; Trapani C
    J Exp Pathol; 1987; 3(4):587-92. PubMed ID: 3454806
    [No Abstract]   [Full Text] [Related]  

  • 27. Genitourinary cancer.
    Ozols RF; Yagoda A
    Cancer Chemother Biol Response Modif; 1990; 11():602-29. PubMed ID: 2171615
    [No Abstract]   [Full Text] [Related]  

  • 28. [Activity of natural killer (NK) cells and their stimulation in patients with hypernephroma].
    Hofmann R; Lehmer A; Reidel G
    Helv Chir Acta; 1984 Oct; 51(3-4):411-5. PubMed ID: 6209242
    [No Abstract]   [Full Text] [Related]  

  • 29. [Natural killer cytolytic activity in renal and prostatic cancer].
    Parra S; Pinochet R; Vargas R; Sepúlveda C; Miranda D; Puente J
    Rev Med Chil; 1994 Jun; 122(6):630-7. PubMed ID: 7732206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Properties of LAK cell activity and LAK-generation in PBL isolated from patients with renal cell carcinoma].
    Hayakawa M; Hatano T; Koyama Y; Masuda T; Higa I; Osawa A
    Nihon Hinyokika Gakkai Zasshi; 1988 Sep; 79(9):1497-503. PubMed ID: 3266646
    [No Abstract]   [Full Text] [Related]  

  • 31. Genitourinary cancer.
    Ozols RF; Yagoda A
    Cancer Chemother Biol Response Modif; 1987; 9():280-302. PubMed ID: 2856337
    [No Abstract]   [Full Text] [Related]  

  • 32. Lymphocyte therapy of renal cell carcinoma.
    Dillman RO
    Expert Rev Anticancer Ther; 2005 Dec; 5(6):1041-51. PubMed ID: 16336095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contemporary Systemic Therapy for Urologic Malignancies in Geriatric Patients.
    Zhao B; Grivas PD
    Clin Geriatr Med; 2015 Nov; 31(4):645-65. PubMed ID: 26476122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical efficacy of interferon-beta (MR-21) in renal cell carcinoma and cancer of the bladder].
    Niijima T
    Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):928-33. PubMed ID: 3694001
    [No Abstract]   [Full Text] [Related]  

  • 35. Interferon as adjunctive treatment for non-metastatic renal cell carcinoma.
    Takahashi S; Tanigawa T; Imagawa M; Mimata H; Nomura Y; Ogata J
    Br J Urol; 1994 Jul; 74(1):11-4. PubMed ID: 8044505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-1 alpha and interleukin-1 beta production in peripheral whole blood from patients with urological cancer.
    Kuo JY; Ohmoto Y; Yoshida O
    Hinyokika Kiyo; 1998 Jun; 44(6):397-402. PubMed ID: 9719938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health Care Disparities in Urologic Oncology: A Systematic Review.
    Das H; Rodriguez R
    Urology; 2020 Feb; 136():9-18. PubMed ID: 31770548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-tumor reactivity of human lymphokine activated killer (LAK) cells against fresh and cultured preparations of renal cell cancer.
    Belldegrun A; Uppenkamp I; Rosenberg SA
    J Urol; 1988 Jan; 139(1):150-5. PubMed ID: 3257274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccination of Urological Cancer Patients With WT1 Peptide-Pulsed Dendritic Cells in Combination With Molecular Targeted Therapy or Conventional Chemotherapy Induces Immunological and Clinical Responses.
    Ogasawara M; Miyashita M; Ota S
    Ther Apher Dial; 2018 Jun; 22(3):266-277. PubMed ID: 29851270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bibliography. Current world literature. Genitourinary system.
    Curr Opin Oncol; 1999 May; 11(3):B116-30. PubMed ID: 10328603
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.